Nvidia’s Expansion Bill Comes Due in Three Currencies: Equity, Guarantees and Advance Payments
Nvidia is no longer just selling chips. It is now underwriting the infrastructure that consumes them — through equity stakes, credit guarantees and cash advanced against future capacity — while simultaneously defending how those chips are used once they leave the factory.
The clearest example of the new playbook landed on October 21, when the company unveiled joint expansion plans with several suppliers, anchored by a $1.1 billion capacity-reservation prepayment to KYEC. That money is earmarked for new test facilities and equipment on US soil, and the program stretches across substrates, advanced packaging, semiconductor testing and optical components — several links of the supply chain at once. Unlike the financing talks still in play elsewhere, this one is a signed, announced commitment.
Talks, Not Signatures, on the Nscale Question
Contrast that with the credit-guarantee discussions Reuters reported: Nvidia is negotiating to extend multi-billion-dollar guarantees to AI cloud provider Nscale, backing the debt financing of a West Virginia data center intended for Anthropic. No agreement had been signed, and the terms could still shift.
The distinction matters for anyone modeling Nvidia’s balance sheet. A guarantee discussion is not a financing commitment. But a completed deal would tie Nvidia to the project through its funding as well as its technology — a deeper form of exposure than simply shipping hardware.
Should investors sell immediately? Or is it worth buying Nvidia?
Capital and collaboration are being braided together on the customer side too. Nvidia plans to invest $3 billion in Meta’s share offering while widening a partnership on Meta’s Muse models and AI agents. Meta, for its part, intends to deploy Nvidia compute and networking products more broadly, including Vera-Rubin systems and Vera CPUs. The investment has been announced and the broader product rollout described as a plan; neither translates into booked revenue or a concrete earnings contribution yet.
The customer build-out got another lift on Tuesday with the Oracle collaboration. The two companies aim to scale Oracle Cloud Infrastructure superclusters built on Nvidia Vera Rubin NVL72 to several gigawatts, and the systems and Vera processors are now generally available on the platform.
Huang Pushes Back on Megaspeed Questions
Running alongside the expansion is a separate matter of oversight. Jensen Huang on Tuesday described Nvidia’s business ties to Singapore-based Megaspeed International as “normal and not unusual,” and said the company had examined whether its GPUs were being diverted illegally to China.
His remarks followed reports of a US investigation into a former Megaspeed executive over alleged espionage. That probe does not establish any wrongdoing by Nvidia, and Huang’s reference to internal checks does not by itself settle every question about how the chips are ultimately used. What his comments do show is that the company is defending the relationship while pointing to its own screening — no more, no less.
November 17 Sets the Reckoning
The next hard data point arrives on November 17, when Nvidia holds a conference call at 2 p.m. Pacific time to discuss results for its third quarter of fiscal 2027 — a period that closed on October 25. Wednesday’s announcement of the call gives investors the first concrete occasion to measure the financial reality against the partnership headlines.
Until then, the picture splits into two layers of a single investor question: how to value Nvidia’s expansion while keeping control risks in view. The partnerships sketch out business opportunity; the export checks define the boundaries within which that opportunity can be pursued. And on Nscale specifically, the decisive detail is not the headline figure but what obligations a final agreement would actually contain.
Ad
Nvidia Stock: New Analysis – 30 October
Fresh Nvidia information released. What’s the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer…
